<DOC>
	<DOCNO>NCT01904604</DOCNO>
	<brief_summary>Food allergy occur immune system react food . The immune system part body protect u illness germ , also cause allergy . Peanut allergy occur 1 - 2 % people United States Western country . There proof allergy peanut increase . Allergic reaction peanut severe life threaten . The way prevent allergic reaction avoid exposure peanut . However , peanut protein find variety food people accidently expose peanut protein . Treatment accidental exposure include antihistamine ( medication like Benadryl ) , injectable epinephrine ( adrenalin ) must carry time . DBV Technologies develop epicutaneous delivery system , patch put peanut protein skin .</brief_summary>
	<brief_title>Peanut Epicutaneous Phase II Immunotherapy Clinical Trial</brief_title>
	<detailed_description>This study evaluate whether peanut epicutaneous immunotherapy protect individual allergic peanut severe allergic reaction , accidentally expose peanut . The study also look safety treatment effect immune system .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Food Hypersensitivity</mesh_term>
	<mesh_term>Peanut Hypersensitivity</mesh_term>
	<mesh_term>Hypersensitivity , Immediate</mesh_term>
	<criteria>Physiciandiagnosed peanut allergy OR convince history peanut allergy A skin prick test positive peanut ( wheal diameter ≥3mm great saline control ) OR detectable peanut specific Immunoglobulin E ( IgE ) ( ImmunoCAP &gt; 0.35 kUA/L ) Positive reaction cumulative dose ≤1044 mg peanut protein initial qualify Oral Food Challenge ( OFC ) Use effective method contraception female childbearing potential prevent pregnancy agree continue practice acceptable method contraception duration participation study Ability perform spirometry maneuver accordance American Thoracic Society ( ATS ) guideline ( 1994 ) . Children age 411 year document inability adequately perform spirometry may enrol Peak Expiratory Flow ( PEF ) &gt; 80 % predict Provide sign informed consent assent indicate History anaphylaxis peanut result hypotension , neurological compromise require mechanical ventilation Participation study use investigational new drug last 30 day Participation interventional study treatment food allergy past 6 month Pregnancy lactation Current know allergy Viaskin Peanut/Placebo patch device excipients Current know allergy placebo allergen ( oat flour ) oral food challenge ( OFC ) Currently buildup phase allergen immunotherapy Severe poorly control atopic dermatitis great mild flare active disease enrollment Forced Expiratory Volume 1 Second ( FEV1 ) value &lt; 80 % predict clinical feature moderate severe persistent asthma baseline severity ( defined 2007 NHLBI Guidelines ) great high daily dos inhale corticosteroid ( &gt; 500mcg Fluticasone equivalent ) Use steroid medication follow manner : history daily oral steroid dose &gt; 1 month past year , burst steroid course past 3 month , &gt; 1 burst oral steroid course past year use oral parenteral steroid nonasthma indication within past 30 day Asthma require &gt; 1 hospitalization past year asthma &gt; 1 Emergency Department ( ED ) visit past 6 month asthma Any previous intubation/mechanical ventilation due allergy asthma Use omalizumab nontraditional form allergen immunotherapy immunomodulatory biologic therapy past year Use betaadrenergic blocker , angiotensinconverting enzyme inhibitor , angiotensinreceptor blocker , calcium channel blocker past 30 day Inability discontinue antihistamine skin test OFC History alcohol drug abuse History cardiovascular disease , uncontrolled hypertension , arrhythmia , chronic lung disease , active eosinophilic gastrointestinal disease , medical condition include immunologic disorder HIV infection , opinion investigator , make subject unsuitable treatment increase risk anaphylaxis poor outcome</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Peanut Allergy</keyword>
	<keyword>Food Allergy</keyword>
	<keyword>Viaskin peanut patch</keyword>
	<keyword>Allergen Immunotherapy</keyword>
	<keyword>Epicutaneous Immunotherapy</keyword>
	<keyword>Whole peanut extract</keyword>
	<keyword>Allergenic product</keyword>
	<keyword>Immediate hypersensitivity</keyword>
</DOC>